⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20887548 | 1.00 | — | — | |
| SCHEMBL18541363 | 1.00 | — | — | |
| SCHEMBL8164627 | 1.00 | — | — | |
| SCHEMBL15808588 | 0.81 | SI (0.48) | — | |
| SCHEMBL11045342 | 0.79 | — | — | |
| SCHEMBL20335736 | 0.78 | GABRR1 (0.39) | — | |
| SCHEMBL20335735 | 0.78 | GABRR1 (0.39) | — | |
| SCHEMBL7946992 | 0.77 | — | — | |
| SCHEMBL30281168 | 0.77 | — | — | |
| SCHEMBL30079523 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022076975-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | ENLIVEN THERAPEUTICS, INC. (US) | 2022-04-14 | — | — | WO | disclosed |